FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 311:1157-1162 November 1, 1984 Number 18 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.

This article has been cited by other articles:

• Hlatky, M. A., Rogers, W. J., Johnstone, I., Boothroyd, D., Brooks, M. M., Pitt, B., Reeder, G., Ryan, T., Smith, H., Whitlow, P., Wiens, R., Mark, D. B., Rosen, A. D., Detre, K., Frye, R. L., The Bypass Angioplasty Revascularization Investiga, (1997). Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery. NEJM 336: 92-99 [Abstract] [Full Text]  
• Mark, D. B., Talley, J. D., Topol, E. J., Bowman, L., Lam, L. C., Anderson, K. M., Jollis, J. G., Cleman, M. W., Lee, K. L., Aversano, T., Untereker, W. J., Davidson-Ray, L., Califf, R. M. (1996). Economic Assessment of Platelet Glycoprotein IIb/IIIa Inhibition for Prevention of Ischemic Complications of High-Risk Coronary Angioplasty. Circulation 94: 629-635 [Abstract] [Full Text]  
• Cohen, D. J., Krumholz, H. M., Sukin, C. A., Ho, K. K.L., Siegrist, R. B., Cleman, M., Heuser, R. R., Brinker, J. A., Moses, J. W., Savage, M. P., Detre, K., Leon, M. B., Baim, D. S. (1995). In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon Angioplasty : Results From a Randomized Clinical Trial. Circulation 92: 2480-2487 [Abstract] [Full Text]  
• Wong, J. B., Sonnenberg, F. A., Salem, D. N., Pauker, S. G. (1990). Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989. ANN INTERN MED 113: 852-871 [Abstract]  
• Lee, T. H., Fukui, T., Weinstein, M. C., Tosteson, A. N.A., Goldman, L. (1988). Cost-Effectiveness of Screening Strategies for Left Main Coronary Artery Disease in Patients with Stable Angina. Med Decis Making 8: 268-278 [Abstract]  
• Schwartz, W. B. (1987). The Inevitable Failure of Current Cost-Containment Strategies: Why They Can Provide Only Temporary Relief. JAMA 257: 220-224 [Abstract]  
• Moore, R. D., Smith, C. R., Holloway, J. J., Lietman, P. S. (1986). Cefotaxime vs Nafcillin and Tobramycin for the Treatment of Serious Infection: Comparative Cost-effectiveness. Arch Intern Med 146: 1153-1157 [Abstract]  
• Rimm, A. A., Barboriak, J. J., Fischer, M. E. (1986). Trends in Coronary Artery Surgery. JAMA 255: 2292-2293 [Abstract]